Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-19-002477

Chief Financial Officer sold 35,000 shares at $203.08 ($7,107,681)

  • Chief Financial Officer acquired 35,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hippel James Chief Financial Officer 2019-05-01 Option exercise +35,000 $86.25 $3,018,750 39,382 D
Hippel James Chief Financial Officer 2019-05-01 Sale −35,000 $203.08 $7,107,681 4,382 D
Derivatives
Hippel James Chief Financial Officer 2019-05-01 Option exercise · Stock Options (Right to buy) +10,000 0 D
Hippel James Chief Financial Officer 2019-05-01 Option exercise · Stock Options (Right to buy) +25,000 0 D
Open-market sales · 35,000 sh · avg $203.08 · $7,107,681
Loading xslF345X03/primarydocument.xml…